Mar 22, 2016 at 17:51 | Source: CNBC-TV18
The World Health Organization (WHO) has issued a Notice of Concern to Cadila Healthcare over a unit in its Moraiya plant that manufactures vaccines.
Feb 16, 2016 at 08:58 | Source: Reuters
To make a new drug in India, companies need permission from the national drug controller after submitting safety and efficacy data including from local clinical trials. For four years after an approved drug is on the market, firms must submit safety reports, including those on adverse drug reactions.
Feb 15, 2016 at 22:01 | Source: CNBC-TV18
The big demand from Budget 2016 is simple: spend more on healthcare. One suggestion to this end is that the government should take a leaf out of the Singapore government's book and create a universal healthcare insurance scheme.
Feb 03, 2016 at 18:27 | Source: Reuters
The virus is spreading rapidly in the Americas, and WHO officials on Tuesday expressed concern that it could hit Africa and Asia as well. No vaccine has been developed so far.
Jan 13, 2016 at 12:37 | Source:
"There are 15 dead, including 12 police, one paramilitary, and two civilians," a local police official told AFP, adding that at least 10 people had been wounded, nine of whom were police and one a civilian.
Dec 23, 2015 at 18:44 | Source: PTI
The Philippines' FDA has approved Dengvaxia for the prevention of disease caused by all four dengue types in individuals from 9-45 years of age living in endemic areas, Sanofi said in a statement.
Dec 14, 2015 at 21:58 | Source: CNBC-TV18
Sanofi is committed to delivering the vaccine to India and is in contact with local authorities in the country for providing the drug, says Dr Anh Wartel, Senior Director, Clinical Development, R&D at Sanofi.
Dec 10, 2015 at 20:54 | Source: Reuters
Sanofi Pasteur, the group's vaccines division, said Mexico had approved the preventive treatment, called Dengvaxia, for all four dengue virus serotypes, but only for patients aged 9 to 45 who live in areas where the disease is endemic
Dec 10, 2015 at 08:12 | Source: PTI
Government has also taken over the task of implementing Pentavalent vaccine in its immunization programme at a cost of Rs 750 crore annually from next year which was earlier being taken care of by the Gavi Board.
Dec 02, 2015 at 11:42 | Source: SME Mentor
India is the world leader in generic pharmaceuticals production and ranks among the top 20 pharma exporting countries. India is also a major vaccine producer and these vaccines are exported to over 150 countries.
Messages on Vaccine »

Web Messenger

Platinum Member


News Now  

Source:BBC - India will provide four new vaccines free of cost as part of a programme to reduce child mortality, Prime Minister Narendra Modi has said. They include one for rotavirus, which kills thousands of children a year. The disease causes dehydration and severe diarrhoea. It spreads via

3.50 PM Jul 4th 2014


Platinum Member



Source:FirstPost - New Delhi: The Indian government Thursday introduced four new vaccines, including one for Japanese Encephalitis (JE), in the national immunisation programme, which will now provide free vaccines against 13 life-threatening diseases to 27 million children annually.The decision

10.00 PM Jul 3rd 2014

Archana Shukla

Platinum Member


Other Market Topics  

Will they find the right strategic partners for this initiative of cheaper vaccines?

10.21 PM Jun 18th 2014


New Member

0 Follower

Panacea Biotec  

not from USFDA , the approval is from WHO Geneva pre qualification , earlier company was doing good tender business for vaccine based on WHO approval , last year their plant was rejected, now they again got approval and Unicef order , good buy and long term target is 300 .

12.53 PM Jun 10th 2014


Platinum Member


Simran Farms  

all dears...simran is almost debt free company having healthy reserves ,having vast experience in poultry sector having vaccine company as a subsidiary name as a simfa lab...i think...simran is a perfect wealth creator in coming days...

12.29 PM Jun 6th 2014


Platinum Member


Jayant Agro-Org  

Adarrsh ji: this gradma story is .. India is the largest producer of vaccines in the world..(by quantity) and these eggs are used for producing vaccines.. Serum institute of India is privately owned company that produces vaccines and used to own shares in the public company that manufactures

12.21 PM May 29th 2014


Silver Member


Bharat Immunologicals and Biologicals Corporation  

Profit making psu mfg polio vaccine and vitamins.expected turnover in 2014-15 likely more than 300 cr

1.18 PM May 28th 2014


Silver Member


Bharat Immuno  

This stock has potential to go in 3 digits. Its a PSU with monopoly over the polio vaccine market in India ... It has starred production of zinc and vitamin tablets also ... The company has over 30 crs in cash in books .. Market cap is only 80 cr... Zero debt company .. Once yhe accumulation phase

3.32 PM May 21st 2014


Silver Member


Bharat Immuno  


8.56 PM May 20th 2014


New Member


Bharat Immuno  

BIBC has started manufacturing vitamin tablets from last six months. Earlier they are making only vaccines. It is turnaround story with target Rs 60 in six months.

6.25 PM May 16th 2014

News across the web »
Apr 27, 2016 at 15:13 | Source: FirstPost
Apr 27, 2016 at 08:13 | Source: FirstPost
Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.